Eliminating Variability: The Solution To Temperature-Sensitive Pharmaceutical Sampling

The approval and increasing use of biological pharmaceuticals has propelled the pharmaceutical and supply chain management industries forward. These biologic drugs treat a variety of disease states, including diabetes and cancer, as well as vaccinate against infectious diseases – providing new treatment options for certain patient populations. However, despite advances across the supply chain, these drugs remain vulnerable throughout the last mile – the final supply chain leg of pharmaceutical products to healthcare providers and patients – due to their temperature-sensitive nature.